Literature DB >> 33833465

Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA.

Alexander N Gorelick1,2, Minsoo Kim1, Walid K Chatila1,2,3, Konnor La4, A Ari Hakimi5, Michael F Berger3,6, Barry S Taylor1,2,3, Payam A Gammage7,8, Ed Reznik9,10,11.   

Abstract

Mitochondrial DNA (mtDNA) encodes protein subunits and translational machinery required for oxidative phosphorylation (OXPHOS). Using repurposed whole-exome sequencing data, in the present study we demonstrate that pathogenic mtDNA mutations arise in tumours at a rate comparable to those in the most common cancer driver genes. We identify OXPHOS complexes as critical determinants shaping somatic mtDNA mutation patterns across tumour lineages. Loss-of-function mutations accumulate at an elevated rate specifically in complex I and often arise at specific homopolymeric hotspots. In contrast, complex V is depleted of all non-synonymous mutations, suggesting that impairment of ATP synthesis and mitochondrial membrane potential dissipation are under negative selection. Common truncating mutations and rarer missense alleles are both associated with a pan-lineage transcriptional programme, even in cancer types where mtDNA mutations are comparatively rare. Pathogenic mutations of mtDNA are associated with substantial increases in overall survival of colorectal cancer patients, demonstrating a clear functional relationship between genotype and phenotype. The mitochondrial genome is therefore frequently and functionally disrupted across many cancers, with major implications for patient stratification, prognosis and therapeutic development.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33833465      PMCID: PMC9304985          DOI: 10.1038/s42255-021-00378-8

Source DB:  PubMed          Journal:  Nat Metab        ISSN: 2522-5812


  58 in total

1.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data.

Authors:  Heng Li
Journal:  Bioinformatics       Date:  2011-09-08       Impact factor: 6.937

2.  A new mutation in the mitochondrial tRNA(Ala) gene in a patient with ophthalmoplegia and dysphagia.

Authors:  M Spagnolo; G Tomelleri; G Vattemi; M Filosto; N Rizzuto; P Tonin
Journal:  Neuromuscul Disord       Date:  2001-07       Impact factor: 4.296

3.  The Cancer Genome Atlas Pan-Cancer analysis project.

Authors:  John N Weinstein; Eric A Collisson; Gordon B Mills; Kenna R Mills Shaw; Brad A Ozenberger; Kyle Ellrott; Ilya Shmulevich; Chris Sander; Joshua M Stuart
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

4.  The Molecular Signatures Database (MSigDB) hallmark gene set collection.

Authors:  Arthur Liberzon; Chet Birger; Helga Thorvaldsdóttir; Mahmoud Ghandi; Jill P Mesirov; Pablo Tamayo
Journal:  Cell Syst       Date:  2015-12-23       Impact factor: 10.304

5.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

6.  Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival.

Authors:  Henrik Hornshøj; Morten Muhlig Nielsen; Nicholas A Sinnott-Armstrong; Michał P Świtnicki; Malene Juul; Tobias Madsen; Richard Sallari; Manolis Kellis; Torben Ørntoft; Asger Hobolth; Jakob Skou Pedersen
Journal:  NPJ Genom Med       Date:  2018-01-11       Impact factor: 8.617

7.  High-confidence assessment of functional impact of human mitochondrial non-synonymous genome variations by APOGEE.

Authors:  Stefano Castellana; Caterina Fusilli; Gianluigi Mazzoccoli; Tommaso Biagini; Daniele Capocefalo; Massimo Carella; Angelo Luigi Vescovi; Tommaso Mazza
Journal:  PLoS Comput Biol       Date:  2017-06-22       Impact factor: 4.475

8.  Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences.

Authors:  Anqi Zhu; Joseph G Ibrahim; Michael I Love
Journal:  Bioinformatics       Date:  2019-06-01       Impact factor: 6.937

9.  Mitochondrial ubiquinol oxidation is necessary for tumour growth.

Authors:  Inmaculada Martínez-Reyes; Luzivette Robles Cardona; Hyewon Kong; Karthik Vasan; Gregory S McElroy; Marie Werner; Hermon Kihshen; Colleen R Reczek; Samuel E Weinberg; Peng Gao; Elizabeth M Steinert; Raul Piseaux; G R Scott Budinger; Navdeep S Chandel
Journal:  Nature       Date:  2020-07-08       Impact factor: 49.962

10.  The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis.

Authors:  Shilpy Joshi; Denis Tolkunov; Hana Aviv; Abraham A Hakimi; Ming Yao; James J Hsieh; Shridar Ganesan; Chang S Chan; Eileen White
Journal:  Cell Rep       Date:  2015-11-19       Impact factor: 9.423

View more
  18 in total

Review 1.  The potential of mitochondrial genome engineering.

Authors:  Pedro Silva-Pinheiro; Michal Minczuk
Journal:  Nat Rev Genet       Date:  2021-12-02       Impact factor: 53.242

2.  Mitochondrial DNA sequence variation and risk of meningioma.

Authors:  Claudine M Samanic; Jamie K Teer; Zachary J Thompson; Jordan H Creed; Sepideh Mokhtari; Brooke L Fridley; L Burt Nabors; Sion L Williams; Kathleen M Egan
Journal:  J Neurooncol       Date:  2021-10-20       Impact factor: 4.130

3.  Mitochondrial mutations in Caenorhabditis elegans show signatures of oxidative damage and an AT-bias.

Authors:  Gus Waneka; Joshua M Svendsen; Justin C Havird; Daniel B Sloan
Journal:  Genetics       Date:  2021-10-02       Impact factor: 4.402

4.  Diet Quality Scores Are Positively Associated with Whole Blood-Derived Mitochondrial DNA Copy Number in the Framingham Heart Study.

Authors:  Jiantao Ma; Xue Liu; Yuankai Zhang; Hanning Cheng; Wencheng Gao; Chao-Qiang Lai; Stacey Gabriel; Namrata Gupta; Ramachandran S Vasan; Daniel Levy; Chunyu Liu
Journal:  J Nutr       Date:  2022-03-03       Impact factor: 4.798

5.  Metabolic resistance to the inhibition of mitochondrial transcription revealed by CRISPR-Cas9 screen.

Authors:  Mara Mennuni; Roberta Filograna; Andrea Felser; Nina A Bonekamp; Patrick Giavalisco; Oleksandr Lytovchenko; Nils-Göran Larsson
Journal:  EMBO Rep       Date:  2021-11-15       Impact factor: 8.807

6.  Genome and metabolome: chance and necessity.

Authors:  Emanuel Gonçalves; Christian Frezza
Journal:  Genome Biol       Date:  2021-09-23       Impact factor: 13.583

Review 7.  Mitochondrial Proteins as Source of Cancer Neoantigens.

Authors:  Gennaro Prota; Ana Victoria Lechuga-Vieco; Gennaro De Libero
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

8.  Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthase.

Authors:  Benjamin J Reisman; Hui Guo; Haley E Ramsey; Madison T Wright; Bradley I Reinfeld; P Brent Ferrell; Gary A Sulikowski; W Kimryn Rathmell; Michael R Savona; Lars Plate; John L Rubinstein; Brian O Bachmann
Journal:  Nat Chem Biol       Date:  2021-12-02       Impact factor: 16.174

9.  Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History.

Authors:  Livius Penter; Satyen H Gohil; Caleb Lareau; Leif S Ludwig; Erin M Parry; Teddy Huang; Shuqiang Li; Wandi Zhang; Dimitri Livitz; Ignaty Leshchiner; Laxmi Parida; Gad Getz; Laura Z Rassenti; Thomas J Kipps; Jennifer R Brown; Matthew S Davids; Donna S Neuberg; Kenneth J Livak; Vijay G Sankaran; Catherine J Wu
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 38.272

10.  Characterization of Mitochondrial Proteome and Function in Luminal A and Basal-like Breast Cancer Subtypes Reveals Alteration in Mitochondrial Dynamics and Bioenergetics Relevant to Their Diagnosis.

Authors:  Ariadna Jazmín Ortega-Lozano; Leopoldo Gómez-Caudillo; Alfredo Briones-Herrera; Omar Emiliano Aparicio-Trejo; José Pedraza-Chaverri
Journal:  Biomolecules       Date:  2022-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.